EXQUISOF (U.S. Trademark Serial Number 86460417) is a United States trademark of Glaxo Group Limited. The goods and services include: Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines The wording “EXQUISOF” has no meaning in a foreign language. . The correspondent is Merilee J. Arevalo of GSK.
This trademark was filed on November 20, 2014 as United States Trademark Application Serial Number 86460417. The trademark application was registered on December 15, 2015 as U.S. Trademark Registration 4869485.
Trademark PTO Status History
July 01, 2022 – CANCELLED SEC. 8 (6-YR)
December 15, 2020 – COURTESY REMINDER – SEC. 8 (6-YR) E-MAILED
December 10, 2019 – ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
December 10, 2019 – TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
December 15, 2015 – REGISTERED-PRINCIPAL REGISTER
September 29, 2015 – OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
September 29, 2015 – PUBLISHED FOR OPPOSITION
September 09, 2015 – NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
View full trademark status information at USPTO
Ownership History
Glaxo Group Limited
Glaxo Group Limited
Glaxo Group Limited
View documents on file at USPTO
File a Trademark or Get Help With Trademark Law
Select IP monitors top trademarks which have been allowed and granted worldwide. We are experts in trademark law. If you are interested in connecting with an IP law attorney or patent law attorney, please contact us via the contact form.